Vascular Access Devices | Market Insights | US | 2022
The US vascular access device market is well-established and only expected to see marginal growth over the forecast period. The market will be driven by the steady growth in the underlying patient population needing medical procedures that require vascular access. However, the maturity of the vascular access market also leads to strong pricing pressures, so most product segments will only see marginal changes in ASPs. Additionally, changes in the standard-of-practice will continue to shift the selection of vascular access device away from PICCs to the midline catheters; this will further mitigate any ASP growth as midline catheters are less expensive than PICCs. Importantly, vascular access devices represent a key component in the care and treatment of patients with COVID-19, therefore the pandemic’s positive and negative impact on procedures, unit sales, and revenues have been incorporated into market projections.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for Vascular Access Devices in the US across an 11-year period.
